Price $11.50 |
Market Cap
411.6M
|
Sector Health Care |
Div. Growth
-50.00%
|
|
P/E
16.9
|
P/B
2.15
|
P/S
2.04
|
Dividend %
5.20%
|
|
P/CF
252.3
|
P/FCF
19.3
|
Op. Cash Flow
35.8K
|
FCF
0.5
|
|
Op. Margin
16.20%
|
Net Margin
12.10%
|
ROE
13.20%
|
ROI
9.60%
|
|
ROA
8.50%
|
EPS Growth
1.70%
|
Current Ratio
6.9
|
Debt/Equity
39.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $7.93 | - | - | 94.6M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $2.26 | - | 10.00% | 14.7M | Strong Buy |
| NantHealth Inc (NH) | $1.31 | - | - | 113.9M | Strong Buy |
| CYANOTECH CORP (CYAN) | $2.40 | - | - | 13.6M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.70 | - | - | 14.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
